Healthcare provider profile · identity verified

Timothy J Hernandez, MD

Family Practice · WEST SAINT PAUL, MN · NPI 1932110079

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	584	162
Lisinopril	Lisinopril	360	104
Metoprolol Succinate	Metoprolol Succinate	262	79
Losartan Potassium	Losartan Potassium	234	64
Amlodipine Besylate	Amlodipine Besylate	226	57
Levothyroxine Sodium	Levothyroxine Sodium	173	44
Gabapentin	Gabapentin	170	46
Simvastatin	Simvastatin	169	50
Omeprazole	Omeprazole	164	49
Hydrochlorothiazide	Hydrochlorothiazide	150	44
Trazodone Hcl	Trazodone Hcl	128	30
Furosemide	Furosemide	125	37
Ozempic	Semaglutide	124	17
Metformin Hcl	Metformin Hcl	123	38
Rosuvastatin Calcium	Rosuvastatin Calcium	123	39
Tamsulosin Hcl	Tamsulosin Hcl	108	34
Atenolol	Atenolol	99	29
Metoprolol Tartrate	Metoprolol Tartrate	87	23
Glipizide Er	Glipizide	78	25
Oxycodone Hcl	Oxycodone Hcl	75	11
Alendronate Sodium	Alendronate Sodium	74	19
Chlorthalidone	Chlorthalidone	70	18
Pantoprazole Sodium	Pantoprazole Sodium	70	23
Doxazosin Mesylate	Doxazosin Mesylate	68	18
Fluoxetine Hcl	Fluoxetine Hcl	67	13
Citalopram Hbr	Citalopram Hydrobromide	65	17
Metformin Hcl Er	Metformin Hcl	65	19
Allopurinol	Allopurinol	61	17
Famotidine	Famotidine	61	20
Nitroglycerin	Nitroglycerin	60	38
Xarelto	Rivaroxaban	58	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	57	13
Amitriptyline Hcl	Amitriptyline Hcl	54	suppressed
Buspirone Hcl	Buspirone Hcl	54	17
Albuterol Sulfate Hfa	Albuterol Sulfate	51	26
Potassium Chloride	Potassium Chloride	51	18
Pravastatin Sodium	Pravastatin Sodium	48	13
Eliquis	Apixaban	46	12
Finasteride	Finasteride	46	14
Fluticasone Propionate	Fluticasone Propionate	45	21
Clopidogrel	Clopidogrel Bisulfate	44	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	44	15
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	43	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	43	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	42	11
Warfarin Sodium	Warfarin Sodium	42	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	42	suppressed
Montelukast Sodium	Montelukast Sodium	40	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	37	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	36	13
Tramadol Hcl	Tramadol Hcl	36	suppressed
Cephalexin	Cephalexin	35	31
Duloxetine Hcl	Duloxetine Hcl	35	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	34	suppressed
Prednisone	Prednisone	34	27
Celecoxib	Celecoxib	33	suppressed
Ondansetron Hcl	Ondansetron Hcl	32	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	32	suppressed
Methocarbamol	Methocarbamol	31	suppressed
Terazosin Hcl	Terazosin Hcl	31	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	29	suppressed
Mirtazapine	Mirtazapine	29	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Ezetimibe	Ezetimibe	27	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	27	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	24	suppressed
Sertraline Hcl	Sertraline Hcl	24	suppressed
Estradiol	Estradiol	23	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	23	suppressed
Amoxicillin	Amoxicillin	22	12
Carvedilol	Carvedilol	21	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	21	suppressed
Alprazolam	Alprazolam	20	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	suppressed
Donepezil Hcl	Donepezil Hcl	20	suppressed
Glipizide	Glipizide	20	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	20	suppressed
Methadone Hcl	Methadone Hcl	20	suppressed
Arnuity Ellipta	Fluticasone Furoate	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Insulin Aspart Flexpen	Insulin Aspart	19	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Farxiga	Dapagliflozin Propanediol	17	suppressed
Mupirocin	Mupirocin	17	12
Pregabalin	Pregabalin	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	16	suppressed
Azithromycin	Azithromycin	16	16
Olanzapine	Olanzapine	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Irbesartan	Irbesartan	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Terbinafine Hcl	Terbinafine Hcl	15	suppressed
Cholestyramine	Cholestyramine (With Sugar)	14	suppressed
Lorazepam	Lorazepam	14	suppressed
Bumetanide	Bumetanide	13	suppressed
Cilostazol	Cilostazol	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Glimepiride	Glimepiride	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	11
Trulicity	Dulaglutide	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Digoxin	Digoxin	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Humulin R U-500 Kwikpen	Insulin Regular, Human	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error